# An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain

> **NCT00771199** · PHASE4 · COMPLETED · sponsor: **Janssen-Cilag Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Cancer, Pain

## Interventions

- **DRUG:** Transdermal Therapeutic System (TTS)-Fentanyl

## Key facts

- **NCT ID:** NCT00771199
- **Lead sponsor:** Janssen-Cilag Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-11
- **Final completion:** 2008-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-09-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00771199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00771199, "An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00771199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*